STU 3 Candidate
This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R4 R3
FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))
{
"resourceType": "CodeSystem",
"id": "v2-0227",
"meta": {
"profile": [
"http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"
]
},
"text": {
"status": "additional",
"div": "<div>!-- Snipped for Brevity --></div>"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-oid",
"valueUri": "urn:oid:2.16.840.1.133883.18.127"
}
],
"url": "http://hl7.org/fhir/v2/0227",
"version": "2.8.2",
"name": "v2 Manufacturers of Vaccines (code=MVX)",
"status": "active",
"experimental": true,
"publisher": "HL7, Inc",
"contact": [
{
"telecom": [
{
"system": "other",
"value": "http://hl7.org"
}
]
}
],
"description": "FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))",
"caseSensitive": false,
"valueSet": "http://hl7.org/fhir/ValueSet/v2-0227",
"content": "complete",
"concept": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Ross Products Division)"
}
],
"code": "AB",
"display": "Abbott Laboratories",
"designation": [
{
"language": "nl",
"value": "Abbott Laboratories"
}
]
},
{
"code": "AD",
"display": "Adams Laboratories, Inc.",
"designation": [
{
"language": "nl",
"value": "Adams Laboratories, Inc."
}
]
},
{
"code": "ALP",
"display": "Alpha Therapeutic Corporation",
"designation": [
{
"language": "nl",
"value": "Alpha Therapeutic Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use AVB]"
}
],
"code": "AR",
"display": "Armour",
"designation": [
{
"language": "nl",
"value": "Armour"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB] CDC Changes made on: Feb. 28, 2006"
}
],
"code": "AVB",
"display": "Aventis Behring L.L.C.",
"designation": [
{
"language": "nl",
"value": "Aventis Behring L.L.C."
}
]
},
{
"code": "AVI",
"display": "Aviron",
"designation": [
{
"language": "nl",
"value": "Aviron"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAH]"
}
],
"code": "BA",
"display": "Baxter Healthcare Corporation",
"designation": [
{
"language": "nl",
"value": "Baxter Healthcare Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)"
}
],
"code": "BAH",
"display": "Baxter Healthcare Corporation",
"designation": [
{
"language": "nl",
"value": "Baxter Healthcare Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Miles, Inc. and Cutter Laboratories)"
}
],
"code": "BAY",
"display": "Bayer Corporation",
"designation": [
{
"language": "nl",
"value": "Bayer Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BPC]"
}
],
"code": "BP",
"display": "Berna Products",
"designation": [
{
"language": "nl",
"value": "Berna Products"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Swiss Serum and Vaccine Institute Berne)"
}
],
"code": "BPC",
"display": "Berna Products Corporation",
"designation": [
{
"language": "nl",
"value": "Berna Products Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use AVB]"
}
],
"code": "CEN",
"display": "Centeon L.L.C.",
"designation": [
{
"language": "nl",
"value": "Centeon L.L.C."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Medical Limited CDC Changes made on: July 14, 2006"
}
],
"code": "CHI",
"display": "Chiron Corporation",
"designation": [
{
"language": "nl",
"value": "Chiron Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use NOV] CDC Changes made on: July 14, 2006"
}
],
"code": "CMP",
"display": "Celltech Medeva Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "Celltech Medeva Pharmaceuticals"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: Feb. 28, 2006"
}
],
"code": "CNJ",
"display": "Cangene Corporation",
"designation": [
{
"language": "nl",
"value": "Cangene Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use PMC]"
}
],
"code": "CON",
"display": "Connaught",
"designation": [
{
"language": "nl",
"value": "Connaught"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "DVC",
"display": "DynPort Vaccine Company, LLC",
"designation": [
{
"language": "nl",
"value": "DynPort Vaccine Company, LLC"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use NOV] CDC Changes made on: July 14, 2006"
}
],
"code": "EVN",
"display": "Evans Medical Limited",
"designation": [
{
"language": "nl",
"value": "Evans Medical Limited"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "GEO",
"display": "GeoVax Labs, Inc.",
"designation": [
{
"language": "nl",
"value": "GeoVax Labs, Inc."
}
]
},
{
"code": "GRE",
"display": "Greer Laboratories, Inc.",
"designation": [
{
"language": "nl",
"value": "Greer Laboratories, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAH]"
}
],
"code": "IAG",
"display": "Immuno International AG",
"designation": [
{
"language": "nl",
"value": "Immuno International AG"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use PMC]"
}
],
"code": "IM",
"display": "Merieux",
"designation": [
{
"language": "nl",
"value": "Merieux"
}
]
},
{
"code": "IUS",
"display": "Immuno-U.S., Inc.",
"designation": [
{
"language": "nl",
"value": "Immuno-U.S., Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(BIKEN)"
}
],
"code": "JPN",
"display": "The Research Foundation for Microbial Diseases of Osaka University",
"designation": [
{
"language": "nl",
"value": "The Research Foundation for Microbial Diseases of Osaka University"
}
]
},
{
"code": "KGC",
"display": "Korea Green Cross Corporation",
"designation": [
{
"language": "nl",
"value": "Korea Green Cross Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use WAL]"
}
],
"code": "LED",
"display": "Lederle",
"designation": [
{
"language": "nl",
"value": "Lederle"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use MBL]"
}
],
"code": "MA",
"display": "Massachusetts Public Health Biologic Laboratories",
"designation": [
{
"language": "nl",
"value": "Massachusetts Public Health Biologic Laboratories"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Massachusetts Public Health Biologic Laboratories)"
}
],
"code": "MBL",
"display": "Massachusetts Biologic Laboratories",
"designation": [
{
"language": "nl",
"value": "Massachusetts Biologic Laboratories"
}
]
},
{
"code": "MED",
"display": "MedImmune, Inc.",
"designation": [
{
"language": "nl",
"value": "MedImmune, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAY]"
}
],
"code": "MIL",
"display": "Miles",
"designation": [
{
"language": "nl",
"value": "Miles"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Michigan Biologic Products Institute)"
}
],
"code": "MIP",
"display": "Bioport Corporation",
"designation": [
{
"language": "nl",
"value": "Bioport Corporation"
}
]
},
{
"code": "MSD",
"display": "Merck & Co., Inc.",
"designation": [
{
"language": "nl",
"value": "Merck & Co., Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly North American Biologicals, Inc.)"
}
],
"code": "NAB",
"display": "NABI",
"designation": [
{
"language": "nl",
"value": "NABI"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAH]"
}
],
"code": "NAV",
"display": "North American Vaccine, Inc.",
"designation": [
{
"language": "nl",
"value": "North American Vaccine, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited)"
}
],
"code": "NOV",
"display": "Novartis Pharmaceutical Corporation",
"designation": [
{
"language": "nl",
"value": "Novartis Pharmaceutical Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "NVX",
"display": "Novavax, Inc.",
"designation": [
{
"language": "nl",
"value": "Novavax, Inc."
}
]
},
{
"code": "NYB",
"display": "New York Blood Center",
"designation": [
{
"language": "nl",
"value": "New York Blood Center"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Ortho Diagnostic Systems, Inc.)"
}
],
"code": "ORT",
"display": "Ortho-Clinical Diagnostics",
"designation": [
{
"language": "nl",
"value": "Ortho-Clinical Diagnostics"
}
]
},
{
"code": "OTC",
"display": "Organon Teknika Corporation",
"designation": [
{
"language": "nl",
"value": "Organon Teknika Corporation"
}
]
},
{
"code": "OTH",
"display": "Other manufacturer",
"designation": [
{
"language": "nl",
"value": "Andere fabrikant"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Parke-Davis)"
}
],
"code": "PD",
"display": "Parkedale Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "Parkedale Pharmaceuticals"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006"
}
],
"code": "PMC",
"display": "sanofi pasteur",
"designation": [
{
"language": "nl",
"value": "sanofi pasteur"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use WAL]"
}
],
"code": "PRX",
"display": "Praxis Biologics",
"designation": [
{
"language": "nl",
"value": "Praxis Biologics"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006"
}
],
"code": "PWJ",
"display": "PowderJect Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "PowderJect Pharmaceuticals"
}
]
},
{
"code": "SCL",
"display": "Sclavo, Inc.",
"designation": [
{
"language": "nl",
"value": "Sclavo, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BPC]"
}
],
"code": "SI",
"display": "Swiss Serum and Vaccine Inst.",
"designation": [
{
"language": "nl",
"value": "Swiss Serum and Vaccine Inst."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)"
}
],
"code": "SKB",
"display": "GlaxoSmithKline",
"designation": [
{
"language": "nl",
"value": "GlaxoSmithKline"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "SOL",
"display": "Solvay Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "Solvay, Pharmaceuticals"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006"
}
],
"code": "TAL",
"display": "Talecris Biotherapeutics",
"designation": [
{
"language": "nl",
"value": "Talecris Biotherapeutics"
}
]
},
{
"code": "UNK",
"display": "Unknown manufacturer",
"designation": [
{
"language": "nl",
"value": "Unknown manufacturer"
}
]
},
{
"code": "USA",
"display": "United States Army Medical Research and Material Command",
"designation": [
{
"language": "nl",
"value": "United States Army Medical Research and Material Command"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "VXG",
"display": "VaxGen",
"designation": [
{
"language": "nl",
"value": "VaxGen"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use WAL]"
}
],
"code": "WA",
"display": "Wyeth-Ayerst",
"designation": [
{
"language": "nl",
"value": "Wyeth-Ayerst"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)"
}
],
"code": "WAL",
"display": "Wyeth-Ayerst",
"designation": [
{
"language": "nl",
"value": "Wyeth-Ayerst"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb. 28, 2006"
}
],
"code": "ZLB",
"display": "ZLB Behring",
"designation": [
{
"language": "nl",
"value": "ZLB Behring"
}
]
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
© HL7.org 2011+. FHIR STU3 Candidate (v1.4.0-8139) generated on Thu, Mar 31, 2016 08:13+1100. QA Page
Links: Search |
Version History |
Table of Contents |
Compare to DSTU2 |
|
Propose a change